|
G3BP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.437870E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.018000E-04 |
| Normal-vs-Stage2 |
5.713700E-02 |
| Normal-vs-Stage3 |
5.59089999999651E-05 |
| Normal-vs-Stage4 |
2.27019999999856E-05 |
| Stage1-vs-Stage2 |
4.473400E-01 |
| Stage1-vs-Stage3 |
1.605820E-01 |
| Stage1-vs-Stage4 |
7.642400E-02 |
| Stage2-vs-Stage3 |
1.051200E-01 |
| Stage2-vs-Stage4 |
4.899900E-02 |
| Stage3-vs-Stage4 |
5.071200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.03820000000255E-05 |
| Normal-vs-AfricanAmerican |
2.878200E-01 |
| Normal-vs-Asian |
1.461040E-03 |
| Caucasian-vs-AfricanAmerican |
1.037430E-01 |
| Caucasian-vs-Asian |
9.657800E-01 |
| AfricanAmerican-vs-Asian |
1.511430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.83440000031976E-07 |
| Normal-vs-Female |
1.559190E-03 |
| Male-vs-Female |
9.904600E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.058500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.363970E-04 |
| Normal-vs-Age(61-80Yrs) |
3.245100E-04 |
| Normal-vs-Age(81-100Yrs) |
7.984000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.944600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.821400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.234400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.936200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.762000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.736400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.278400E-02 |
| Classical-VS-Follicular |
7.459800E-01 |
| Classical-VS-Other |
5.230400E-02 |
| Classical-VS-Normal |
6.166200E-04 |
| Tall-VS-Follicular |
5.276000E-02 |
| Tall-VS-Other |
2.470800E-01 |
| Tall-VS-Normal |
8.24409999999887E-05 |
| Follicular-VS-Other |
1.015430E-01 |
| Follicular-VS-Normal |
1.412150E-02 |
| Other-VS-Normal |
1.498710E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.038610E-03 |
| Normal-vs-N1 |
1.69231999999075E-05 |
| N0-vs-N1 |
4.087500E-02 |
|
|
